Expert Interviews

Panelists discuss how NK receptor antagonists can be strategically positioned as core nonhormonal options within the broader VMS treatment landscape.

Panelists discuss how NK receptor antagonism may improve mood and sleep quality, linking thermoregulation with broader emotional and cognitive health benefits.

Symptoms of the menopausal transition can be so disruptive that women consider leaving employment and yet many report misdiagnosis and inappropriate treatment.

Experts discuss the utility of the STOP-Bang questionnaire as a simple, sensitive screening tool for obstructive sleep apnea (OSA) in primary care, highlighting its strengths and limitations, the importance of clinical judgment in interpreting results, and the value of complementary tools such as the Epworth Sleepiness Scale in supporting a comprehensive, patient-centered approach to OSA diagnosis and management.

Experts discuss the widespread underdiagnosis of obstructive sleep apnea (OSA), emphasizing its significant impact on quality of life and comorbid conditions, the critical role of primary care in early detection, the importance of family input in recognizing symptoms, and the need for proactive, multidisciplinary strategies to ensure timely diagnosis and effective management.

Clevenger, a professor of nursing at Emory University, shares practical strategies to manage agitation in Alzheimer disease, emphasizing that this symptom is treatable.

Panelists discuss how NK1 receptor antagonists show promise beyond VMS, suggesting wider therapeutic potential across neurological and systemic conditions.

Panelists discuss how NK receptor antagonists deliver fast symptom relief with strong safety profiles, improving adherence and clinical confidence in their use.

Nearly one-third of caregivers hesitate to discuss agitation in a patient with AD. Emory's Clevenger, shares why and how clinicians can proactively address this barrier.

Emory's Clevenger discusses the neurotransmitter dysregulation behind agitation in AD and why memory-focused care doesn't address behavioral symptoms.